Cedars-sinai Medical Center
Clinical trials sponsored by Cedars-sinai Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Triple-Drug combo save Women's hearts when arteries look clear? Results expected Sep 2026 (estimated)
- New study aims to cut opioid use in transgender surgery recovery Results expected Sep 2026 (estimated)
- New online tool aims to boost colorectal cancer screening Results expected Sep 2026 (estimated)
- New study checks heat risk to throat during heart procedure Results expected Oct 2026 (estimated)
- AI takes on sonographers: a 4,000-Patient trial to sharpen heart imaging Results expected Nov 2026 (estimated)
-
Antifungal drug targets gut fungus in Crohn's patients with genetic risk
Disease control Stopped earlyThis study tested the antifungal drug posaconazole in people with active Crohn's disease who carry a specific gene variant (CARD9 S12N). The goal was to see if reducing a type of fungus in the gut could lower inflammation and improve symptoms. The trial was stopped early and incl…
Phase 4 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New study tests safer pain control for teens after spine surgery
Symptom relief Stopped earlyThis study looked at two different combinations of anesthesia medicines given through an IV to teenagers having surgery for scoliosis. The goal was to see if one combination leads to less pain and less need for opioid painkillers after surgery. The study was small and ended early…
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC